Corami Biotech received support from LaunchTN and InvestTN for its intrapericardial route for therapeutic delivery.
Public source
Publisher name
Public post
Our team at Corami Biotech is grateful for the support we get from LaunchTN and #InvestTN. LaunchTN steps up to the plate not only with direct or matching investment(s)…
Company
Corami Biotech
A New Route to The Heart
- Industry
- Biotechnology Research
- Location
- Memphis, US
- Company size
- 2–10 employees
About Corami Biotech
Corami Biotech is creating a novel platform accessing a unique space within the outer layers of the heart for therapeutic delivery and placement to transform the way heart disease is treated.
See moreLatest activity
Latest activity from Corami Biotech
4 signals
Products & Services
Corami Biotech is working on establishing the intrapericardial route for the delivery and placement of therapeutics to change heart treatment and save lives.
Partnerships
Corami Biotech has received support from Epicenter Memphis and the local community.
Products & Services
Corami Biotech is establishing the intrapericardial route for therapeutic delivery and placement to fundamentally change treatment of many heart conditions.
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
LaunchTN
LaunchTN partners beyond et al. lead the NIH SBIR/STTR Cohort designed for companies preparing an NIH SBIR/STTR application for the Jan. 5, 2027 deadline.
Partnerships
HeartBeat.bio AG
HeartBeat.bio AG announced a strategic research collaboration with CubaseBio, supported by approximately €1M in Eurostars funding, through the FACTS-3D project.
Partnerships
Portal Innovations
Portal Innovations partnered with the Founders Compass program and the Rhode Island Life Science Hub to offer early-stage life sciences companies funding support for lab space at Ocean State Labs.
Partnerships
MOBILion Systems, Inc.
MOBILion Systems, Inc. partnered with John McLean's team at Vanderbilt University
Partnerships
NTx Bio